Clinical Trial Update: Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing platelet resistance with ticagrelor versus standard-dose clopidogrel in patients with Acute Coronary Syndrome and Chronic Kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Syndrome
• End-stage Renal Disease

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: Ping-Yen Liu | Conditions: Acute Coronary Syndrome, Chronic Kidney Disease | Phase 4 | Status: UNKNOWN